Form 8-K - Current report:
SEC Accession No. 0000950170-24-107615
Filing Date
2024-09-18
Accepted
2024-09-18 09:01:15
Documents
17
Period of Report
2024-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sclx-20240917.htm   iXBRL 8-K 47653
2 EX-10.1 sclx-ex10_1.htm EX-10.1 34049
3 EX-99.1 sclx-ex99_1.htm EX-99.1 28050
4 GRAPHIC img191798281_0.jpg GRAPHIC 14272
5 GRAPHIC img191798281_1.jpg GRAPHIC 8177
6 GRAPHIC img191798281_2.jpg GRAPHIC 11277
7 GRAPHIC img191798281_3.jpg GRAPHIC 17053
  Complete submission text file 0000950170-24-107615.txt   349564

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20240917.xsd EX-101.SCH 53642
19 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20240917_htm.xml XML 6354
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241306276
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)